Archive > Volume 28 Issue 4 > 2021,28(4):384-391. DOI:10.3872/j.issn.1007-385X.2021.04.011 Prev Next

Review

Research progress on tumor-associated immunocytes as markers for predicting and assessing the efficacy of anti-PD-1/PD-L1 therapy

您是第位访问者
Chinese Journal Of Cancer Biotheray ® 2025 All Rights Reserved
Supported by:Beijing E-Tiller Technology Development Co., Ltd.